Home » GlaxoSmithKline Signs Worldwide Acquisition for Toctino
GlaxoSmithKline Signs Worldwide Acquisition for Toctino
Stiefel signs worldwide acquisition and license agreement for Toctino. Stiefel, a GlaxoSmithKline company, announced that it has entered into a worldwide agreement to acquire Toctino (alitretinoin) from Basilea Pharmaceutica.
Fox Business
Fox Business
Upcoming Events
-
07May
-
14May
-
30May